Eliana Merle
Stock Analyst at Barclays
Total Price Targets
19
Stocks Covered
12
Sectors
Healthcare
Most Recent
Mar 6, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Eliana Merle
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | $923.00 | $703.72 | +31.2% | 1 | Mar 6, 2026 |
| BMRN | BioMarin Pharmaceutical Inc. | $105.00 | $54.20 | +93.7% | 2 | Mar 3, 2026 |
| GOSS | Gossamer Bio, Inc. | $0.30 | $0.36 | -16.4% | 1 | Feb 24, 2026 |
| PTCT | PTC Therapeutics, Inc. | $120.00 | $65.06 | +84.4% | 1 | Feb 23, 2026 |
| VRTX | Vertex Pharmaceuticals Incorporated | $607.00 | $425.06 | +42.8% | 2 | Feb 17, 2026 |
| KYMR | Kymera Therapeutics, Inc. | $133.00 | $81.54 | +63.1% | 2 | Jan 27, 2026 |
| INSM | Insmed Incorporated | $231.00 | $133.75 | +72.7% | 1 | Jan 27, 2026 |
| BBIO | BridgeBio Pharma, Inc. | $72.00 | $69.25 | +4.0% | 2 | Apr 30, 2025 |
| RVMD | Revolution Medicines, Inc. | $71.00 | $140.52 | -49.5% | 1 | Jan 8, 2025 |
| MRNA | Moderna, Inc. | $151.00 | $44.65 | +238.2% | 4 | May 7, 2024 |
| MDGL | Madrigal Pharmaceuticals, Inc. | $410.00 | $516.66 | -20.6% | 1 | Mar 15, 2024 |
| ARVN | Arvinas, Inc. | $123.00 | $10.55 | +1065.6% | 1 | May 20, 2021 |
Recent Activity
- Mar 6, 2026— Set$923.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Mar 3, 2026— Set$105.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Feb 24, 2026— Set$0.30price target onGOSS(Gossamer Bio, Inc.)
- Feb 23, 2026— Set$120.00price target onPTCT(PTC Therapeutics, Inc.)
- Feb 17, 2026— Set$607.00price target onVRTX(Vertex Pharmaceuticals Incorporated)
- Jan 27, 2026— Set$231.00price target onINSM(Insmed Incorporated)
- Jan 27, 2026— Set$133.00price target onKYMR(Kymera Therapeutics, Inc.)
- Aug 5, 2025— Set$553.00price target onVRTX(Vertex Pharmaceuticals Incorporated)
- Apr 30, 2025— Set$72.00price target onBBIO(BridgeBio Pharma, Inc.)
- Jan 8, 2025— Set$71.00price target onRVMD(Revolution Medicines, Inc.)
- May 28, 2024— Set$47.00price target onBBIO(BridgeBio Pharma, Inc.)
- May 7, 2024— Set$151.00price target onMRNA(Moderna, Inc.)
- Apr 22, 2024— Set$119.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Mar 27, 2024— Set$143.00price target onMRNA(Moderna, Inc.)
- Mar 15, 2024— Set$410.00price target onMDGL(Madrigal Pharmaceuticals, Inc.)
- Jun 26, 2023— Set$191.00price target onMRNA(Moderna, Inc.)
- Jan 21, 2022— Set$221.00price target onMRNA(Moderna, Inc.)
- May 20, 2021— Set$123.00price target onARVN(Arvinas, Inc.)
- May 20, 2021— Set$80.00price target onKYMR(Kymera Therapeutics, Inc.)
Frequently Asked Questions
Who is Eliana Merle?
Eliana Merle is a stock analyst at Barclays covering 12 stocks primarily in Healthcare. They have issued 19 price targets since May 20, 2021.
What stocks does Eliana Merle cover?
Eliana Merle currently covers 12 stocks, including MRNA, BMRN, VRTX, KYMR, BBIO.
What is Eliana Merle's latest price target?
Eliana Merle's most recent price target was $923.00 on REGN (Regeneron Pharmaceuticals, Inc.), set on Mar 6, 2026.
What is Eliana Merle's highest price target?
Eliana Merle's highest issued price target is $923.00 on REGN, set on Mar 6, 2026.
More Analysts at Barclays
Coverage based on publicly published price targets. Not investment advice.